UROsphere announces that OSEO Innovation has awarded a grant over a 2-year period to expand its experimental research platform for early stage drug development. The funding will be used to develop innovative in vivo and in vitro models to offer a wider range of assays for genitourinary pathologies.
OSEO innovation (France’s national agency for industrial innovation) funds innovative, technology-oriented projects for commercialization in France and abroad.
